X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Norway Pharmaceutical Companies (2024 - 2029)

Several prominent companies in the pharmaceutical industry, including those specializing in research, development, and production of various medical treatments, are making significant strides in their respective fields. These businesses are recognized for their commitment to innovation, with a focus on enhancing patient care and addressing critical health challenges. They continue to invest in research and development to bring innovative solutions to the market. From developing new drugs to improving existing ones, these corporations play a crucial role in advancing global health.

Home Market Analysis Healthcare Research Pharmaceuticals Research Norway Pharmaceutical Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Norway Pharmaceutical Market

This report lists the top Norway Pharmaceutical companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Norway Pharmaceutical industry.

  1. Abbvie

  2. Bayer

  3. Boehringer Ingelheim

  4. GlaxoSmithKline

  5. AstraZeneca

*Disclaimer: Top companies sorted in no particular order

Norway Pharmaceutical Market Major Players

Norway Pharmaceutical Market Concentration

Norway Pharmaceutical Market Concentration

Norway Pharmaceutical Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Good Societal and Economical Conditions

      2. 4.2.2 Rising Incidence of Chronic Disease

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Rules

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By ATC/Therapeutic Class

      1. 5.1.1 Cardiovascular System

      2. 5.1.2 Dermatologicals

      3. 5.1.3 Genito Urinary System and Sex Hormones

      4. 5.1.4 Anti-infective for Systemic Use

      5. 5.1.5 Antineoplastic and Immunomodulating Agents

      6. 5.1.6 Musculoskeletal System

      7. 5.1.7 Nervous System

      8. 5.1.8 Respiratory System

      9. 5.1.9 Other ATC/Therapeutic Classes

    2. 5.2 By Drug Type

      1. 5.2.1 Branded

      2. 5.2.2 Generic

    3. 5.3 By Prescription Type

      1. 5.3.1 Prescription Drugs (Rx)

      2. 5.3.2 Over the Counter (OTC) Drugs

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc.

      2. 6.1.2 AstraZeneca

      3. 6.1.3 Bayer AG

      4. 6.1.4 Boehringer Ingelheim

      5. 6.1.5 GSK plc

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 Bristol Myers Squibb Company

      8. 6.1.8 Eli Lilly and Company

      9. 6.1.9 Merck & Co., Inc.

      10. 6.1.10 Sanofi SA

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Norway Pharmaceutical Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Norway Pharmaceutical Market Companies Summary

The pharmaceutical landscape in Norway has been significantly impacted by the COVID-19 pandemic. The government's rapid shutdown measures affected the entire economy, including the operations of pharmaceutical firms and research entities. Despite the country's crucial role in international public-private partnerships to combat COVID-19, criticisms have been raised regarding the timing and extent of demands made on the pharmaceutical sector. This has resulted in a notable impact on the pharmaceutical market in Norway. However, Norway's pharmaceutical market remains an attractive destination for firms looking to establish a base or form partnerships, thanks to its advanced clinical and medical capabilities in key sectors like neuroscience and cancer. The presence of key market players, product launches, and mergers and acquisitions are expected to spur market growth. For instance, a specialty pharmaceutical firm recently launched a first-of-its-kind generic medication in Norway. Furthermore, the inclusion of Norwegian patients in global clinical trials exposes the country's healthcare system to broader perspectives. Despite stringent regulatory rules for pharmaceutical products, the market is expected to grow in the coming years.

Explore More

Norway Pharmaceutical Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 AbbVie Inc.

      2. 1.1.2 AstraZeneca

      3. 1.1.3 Bayer AG

      4. 1.1.4 Boehringer Ingelheim

      5. 1.1.5 GSK plc

      6. 1.1.6 F. Hoffmann-La Roche Ltd

      7. 1.1.7 Bristol Myers Squibb Company

      8. 1.1.8 Eli Lilly and Company

      9. 1.1.9 Merck & Co., Inc.

      10. 1.1.10 Sanofi SA

    2. *List Not Exhaustive

Norway Pharmaceutical Companies FAQs

AbbVie Inc., Bayer AG, Boehringer Ingelheim, GSK plc and AstraZeneca are the major companies operating in the Norway Pharmaceutical Market.

Norway Pharmaceutical Market Report Snapshots

Norway Pharmaceutical Market Size & Share Analysis - Growth, Trends and Forecasts (2024 - 2029)